ANNEX IISupplementary provisions
ANNEX II In Part D of the Annex to Implementing Regulation (EU) No 540/2011, the following entry is added: No. Common Name, Identification Numbers IUPAC Name Purity ( 1 ) Date of approval Expiration of approval Specific provisions ‘ 35 Bacillus amyloliquefaciens IT-45 n.a. The nominal content of Bacillus amyloliquefaciens IT-45 in the technical product and formulation is: minimum: 2 x 10 13 CFU/kg, maximum: 6 x 10 14 CFU/kg. No relevant impurities 27 February 2022 27 February 2037 For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on Bacillus amyloliquefaciens IT-45 shall be taken into account. ( 1 ) Further details on the identity and the specification of the active substance are provided in the review report.’